FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059343046> ?p ?o ?g. }

• W2059343046 endingPage "276" @default.
• W2059343046 startingPage "270" @default.
• W2059343046 abstract "OBJECTIVE: Weight gain is associated with treatment with many psychotropic agents. Nizatidine, H2 receptor antagonist, has been proposed to have weight-reducing effects. This was a 12-week, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of nizatidine in reducing/limiting weight gain in patients with schizophrenia who have been under treatment with olanzapine. METHOD: Patients receiving olanzapine (2 to 6 months) and weight gain > 5% of their body weight during olanzapine treatment were randomly assigned to receive nizatidine 600 mg or placebo for up to 12 weeks. Change in psychopathology was assessed using Brief Psychiatric Rating Scale scores from baseline to endpoint. Safety was assessed using the Safety Assessed Software, assessment of glucose and lipid blood levels, and treatment-emergent adverse events. RESULTS: Out of 54 patients enrolled in this analysis, 45 completed the protocol. The mean weight change prior randomization was 7.6 kg and 7.3 kg for those randomized to placebo and nizatidine, respectively (p = 0.828). Patients receiving placebo and nizatidine had a mean weight gain of 12.3% (0.7 kg) and 12% (1.1 kg) from baseline to endpoint, respectively (p = 0.9). Patients from both groups experienced a statistically significant decrease on the Brief Psychiatric Rating Scale mean score from baseline to endpoint. Treatment-emergent adverse events were reported by 18.5% and 25.9% on the placebo and nizatidine group, respectively. There were no statistically significant differences in glucose and lipid blood levels from baseline to endpoint and between groups. CONCLUSIONS: The concomitant use of olanzapine with nizatidine was not effective in controlling weight gain in patients who had previously gained weight during treatment with olanzapine when compared to placebo." @default.
• W2059343046 created "2016-06-24" @default.
• W2059343046 creator A5000015532 @default.
• W2059343046 creator A5002807070 @default.
• W2059343046 creator A5010749069 @default.
• W2059343046 creator A5034935673 @default.
• W2059343046 creator A5057483761 @default.
• W2059343046 creator A5067322068 @default.
• W2059343046 creator A5089189420 @default.
• W2059343046 date "2006-12-01" @default.
• W2059343046 modified "2023-10-18" @default.
• W2059343046 title "Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine" @default.
• W2059343046 cites W2111105929 @default.
• W2059343046 doi "https://doi.org/10.1590/s1516-44462006005000007" @default.
• W2059343046 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17242805" @default.
• W2059343046 hasPublicationYear "2006" @default.
• W2059343046 type Work @default.
• W2059343046 sameAs 2059343046 @default.
• W2059343046 citedByCount "21" @default.
• W2059343046 countsByYear W20593430462012 @default.
• W2059343046 countsByYear W20593430462014 @default.
• W2059343046 countsByYear W20593430462015 @default.
• W2059343046 countsByYear W20593430462017 @default.
• W2059343046 countsByYear W20593430462018 @default.
• W2059343046 countsByYear W20593430462021 @default.
• W2059343046 countsByYear W20593430462022 @default.
• W2059343046 countsByYear W20593430462023 @default.
• W2059343046 crossrefType "journal-article" @default.
• W2059343046 hasAuthorship W2059343046A5000015532 @default.
• W2059343046 hasAuthorship W2059343046A5002807070 @default.
• W2059343046 hasAuthorship W2059343046A5010749069 @default.
• W2059343046 hasAuthorship W2059343046A5034935673 @default.
• W2059343046 hasAuthorship W2059343046A5057483761 @default.
• W2059343046 hasAuthorship W2059343046A5067322068 @default.
• W2059343046 hasAuthorship W2059343046A5089189420 @default.
• W2059343046 hasBestOaLocation W20593430461 @default.
• W2059343046 hasConcept C118552586 @default.
• W2059343046 hasConcept C126322002 @default.
• W2059343046 hasConcept C142724271 @default.
• W2059343046 hasConcept C147583825 @default.
• W2059343046 hasConcept C168563851 @default.
• W2059343046 hasConcept C170493617 @default.
• W2059343046 hasConcept C197934379 @default.
• W2059343046 hasConcept C203092338 @default.
• W2059343046 hasConcept C204243189 @default.
• W2059343046 hasConcept C204787440 @default.
• W2059343046 hasConcept C27081682 @default.
• W2059343046 hasConcept C2776412080 @default.
• W2059343046 hasConcept C2776619155 @default.
• W2059343046 hasConcept C2776885963 @default.
• W2059343046 hasConcept C2776921671 @default.
• W2059343046 hasConcept C2778528637 @default.
• W2059343046 hasConcept C2779727114 @default.
• W2059343046 hasConcept C2780135775 @default.
• W2059343046 hasConcept C2780320433 @default.
• W2059343046 hasConcept C2780494398 @default.
• W2059343046 hasConcept C2781353949 @default.
• W2059343046 hasConcept C42219234 @default.
• W2059343046 hasConcept C71924100 @default.
• W2059343046 hasConceptScore W2059343046C118552586 @default.
• W2059343046 hasConceptScore W2059343046C126322002 @default.
• W2059343046 hasConceptScore W2059343046C142724271 @default.
• W2059343046 hasConceptScore W2059343046C147583825 @default.
• W2059343046 hasConceptScore W2059343046C168563851 @default.
• W2059343046 hasConceptScore W2059343046C170493617 @default.
• W2059343046 hasConceptScore W2059343046C197934379 @default.
• W2059343046 hasConceptScore W2059343046C203092338 @default.
• W2059343046 hasConceptScore W2059343046C204243189 @default.
• W2059343046 hasConceptScore W2059343046C204787440 @default.
• W2059343046 hasConceptScore W2059343046C27081682 @default.
• W2059343046 hasConceptScore W2059343046C2776412080 @default.
• W2059343046 hasConceptScore W2059343046C2776619155 @default.
• W2059343046 hasConceptScore W2059343046C2776885963 @default.
• W2059343046 hasConceptScore W2059343046C2776921671 @default.
• W2059343046 hasConceptScore W2059343046C2778528637 @default.
• W2059343046 hasConceptScore W2059343046C2779727114 @default.
• W2059343046 hasConceptScore W2059343046C2780135775 @default.
• W2059343046 hasConceptScore W2059343046C2780320433 @default.
• W2059343046 hasConceptScore W2059343046C2780494398 @default.
• W2059343046 hasConceptScore W2059343046C2781353949 @default.
• W2059343046 hasConceptScore W2059343046C42219234 @default.
• W2059343046 hasConceptScore W2059343046C71924100 @default.
• W2059343046 hasIssue "4" @default.
• W2059343046 hasLocation W20593430461 @default.
• W2059343046 hasLocation W20593430462 @default.
• W2059343046 hasOpenAccess W2059343046 @default.
• W2059343046 hasPrimaryLocation W20593430461 @default.
• W2059343046 hasRelatedWork W1711188166 @default.
• W2059343046 hasRelatedWork W1979518602 @default.
• W2059343046 hasRelatedWork W2019692077 @default.
• W2059343046 hasRelatedWork W2027198501 @default.
• W2059343046 hasRelatedWork W2029364078 @default.
• W2059343046 hasRelatedWork W2050056114 @default.
• W2059343046 hasRelatedWork W2070735132 @default.
• W2059343046 hasRelatedWork W2076931387 @default.
• W2059343046 hasRelatedWork W2088495147 @default.
• W2059343046 hasRelatedWork W4252647794 @default.
• W2059343046 hasVolume "28" @default.

• next